Clinical trials
Active, not recruiting Phase 2 trials in Bulgaria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 17 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Sanofi | 3 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Immunovant Sciences GmbH | 2 |
| Janssen Research & Development, LLC | 2 |
| Upstream Bio Inc. | 2 |
| Vir Biotechnology, Inc. | 2 |
| argenx | 2 |
| Aligos Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 7 |
| Crohn Disease | 4 |
| Dermatitis, Atopic | 4 |
| Asthma | 3 |
| Autoimmune Diseases | 3 |
| Breast Neoplasms | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Arthritis, Rheumatoid | 2 |
| Bronchial Diseases | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.